Study reveals genetic variants are more common in Parkinson’s disease patients
The study revealed that 13% of patients have a genetic form of the neurological disease
Read More
Tag: neurodegenerative conditions
Study finds Parkinson’s disease SLT more effective than one used in NHS
The progressive neurodegenerative condition affects around 153,000 people in the UK
Read More
US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
The progressive neurodegenerative condition affects more than ten million people worldwide
Read More
New study reveals how brain cell communication is linked to Alzheimer’s disease
Two support cells, microglia and astrocytes, were found to communicate with each other
Read More
Roche partners with Cardiff researchers to uncover new research into dementia
Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions
Read More
New programme shown to help dementia patients live independently
The neurodegenerative condition currently affects over 944,000 people in the UK
Read More
Key Parkinson’s protein could offer new potential targets for treatment
The findings could lead to new treatments to target the mTOR and ease PD symptoms
Read More
Cognitive decline in early Alzheimer’s could stem from serotonin loss
MCI patients had 25% lower levels of serotonin compared to healthy patients
Read More
AstronauTx completes £48m series A financing for Alzheimer’s disease
The financing will support the biotech’s clinical study of people with AD as a lead programme
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
